摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-苯氧基-1-丙醇 | 6180-61-6

中文名称
3-苯氧基-1-丙醇
中文别名
丙二醇苯醚;1,3-丙二醇单苯醚
英文名称
3-phenoxypropanol
英文别名
3-phenoxy-propan-1-ol;3-Phenoxypropan-1-ol
3-苯氧基-1-丙醇化学式
CAS
6180-61-6
化学式
C9H12O2
mdl
——
分子量
152.193
InChiKey
AWVDYRFLCAZENH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    83-85 °C
  • 密度:
    1.04
  • 最大波长(λmax):
    260nm(lit.)
  • 保留指数:
    1371
  • 稳定性/保质期:
    在常温常压下保持稳定,应避免与不相容的材料接触。

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    11
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    29.5
  • 氢给体数:
    1
  • 氢受体数:
    2

安全信息

  • 危险品标志:
    Xn
  • 安全说明:
    S24/25,S26,S37/39
  • 危险类别码:
    R22,R36/37/38
  • 海关编码:
    2909499000
  • 储存条件:
    密封保存,应储存在阴凉干燥的仓库中。

SDS

SDS:649c5ffb5d755446d7e024bc478608c0
查看
Name: 3-Phenoxy-1-propanol 97% Material Safety Data Sheet
Synonym: 1-Phenoxypropan-2-ol;propylenephenoxytho
CAS: 6180-61-6
Section 1 - Chemical Product MSDS Name:3-Phenoxy-1-propanol 97% Material Safety Data Sheet
Synonym:1-Phenoxypropan-2-ol;propylenephenoxytho

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
6180-61-6 3-henoxy-1-propanol 97 228-228-8
Hazard Symbols: None Listed.
Risk Phrases: None Listed.

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause irritation of the digestive tract. The toxicological properties of this substance have not been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.
Chronic:
None

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid if irritation develops or persists. Flush skin with plenty of soap and water.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Never give anything by mouth to an unconscious person. Get medical aid.
Inhalation:
Remove from exposure and move to fresh air immediately. Get medical aid if cough or other symptoms appear.
Notes to Physician:

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container.

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation. Use with adequate ventilation.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 6180-61-6: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Liquid
Color: Clear
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 83 - 85 deg C @ .05mm Hg
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: > 112 deg C (> 233.60 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density: 1.0450g/cm3
Molecular Formula: C9H12O2
Molecular Weight: 152.19

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures. Stability unknown.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents Hazardous Decomposition Products:
Carbon monoxide, carbon dioxide.
Hazardous Polymerization: Will not occur.

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 6180-61-6 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
3-henoxy-1-propanol - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 6180-61-6: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 6180-61-6 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 6180-61-6 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A


制备方法与用途

化学性质
无色透明液体,微有水果香味。作为一种绿色环保且高沸点的助剂,丙二醇苯醚无毒环保,并能显著降低挥发性有机化合物(VOC)含量。它具有较高的沸点、良好的混溶性和适中的挥发速率,表现出优异的聚结和偶合能力,从而显著提高涂料涂膜的流平性、光泽和丰满度。作为一种优良的高沸点溶剂和改性剂,丙二醇苯醚可以替代毒性或气味较大的异佛尔酮、DBE以及乙二醇醚等。其化学结构中具备两个强溶解能力的基团——醚键和羟基,使其既能溶解憎水化合物,又能溶解水溶性化合物,因此被誉为“万能溶剂”。

用途
丙二醇苯醚广泛应用于建筑涂料、高档汽车涂料及汽车修补涂料、电泳涂料、船舶集装箱涂料、木器涂料以及卷材和卷钢涂料等多种类型的助溶剂。

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2
    • 3

反应信息

  • 作为反应物:
    描述:
    3-苯氧基-1-丙醇氧气2-碘酰基苯甲酸 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 18.0h, 生成 苯氧乙酸
    参考文献:
    名称:
    Unexpected dehomologation of primary alcohols to one-carbon shorter carboxylic acids using o-iodoxybenzoic acid (IBX)
    摘要:
    IBX提供了一种新颖、高度选择性的醇脱同分异构化,将其转化为相应的碳数减少一个单位的羧酸。
    DOI:
    10.1039/c3cc49160a
  • 作为产物:
    描述:
    3-苯氧基丙基三氯硅烷 在 potassium fluoride 、 potassium hydrogencarbonate双氧水 作用下, 以 四氢呋喃甲醇 为溶剂, 反应 1.0h, 生成 3-苯氧基-1-丙醇
    参考文献:
    名称:
    将硅烷自由基加成到烯烃上,然后氧化
    摘要:
    使用三乙基硼烷作为引发剂,与二烯烃反应后,苯二甲基硅烷和三氯硅烷显示出有效的自由基氢化硅烷化反应。可以将三氯硅烷反应中的加合物氧化,以高收率得到醇。此两步过程导致烯烃的反马氏水合。 加成反应-醇-烯烃-自由基反应-硅烷
    DOI:
    10.1055/s-0031-1289568
点击查看最新优质反应信息

文献信息

  • Dihalopropene compounds, insecticidal/acaricidal agents containing same,
    申请人:Sumitomo Chemical Company, Limited
    公开号:US05872137A1
    公开(公告)日:1999-02-16
    The dihalopropene compounds of the general formula \x9bI! have excellent insecticidal/acaricidal activity, so that they are satisfactorily effective for the control of noxious insects, mites and ticks.
    通用公式\x9bI!的二卤代丙烯化合物具有出色的杀虫/杀螨活性,因此它们对有害昆虫、螨和蜱的控制效果令人满意。
  • Synthesis of Potent Cytotoxic Epidithiodiketopiperazines Designed for Derivatization
    作者:Chase R. Olsson、Joshua N. Payette、Jaime H. Cheah、Mohammad Movassaghi
    DOI:10.1021/acs.joc.9b03371
    日期:2020.4.3
    We describe our design, synthesis, and chemical study of a set of functional epidithiodiketopiperazines (ETPs) and evaluation of their activity against five human cancer cell lines. Our structure-activity relationship-guided substitution of ETP alkaloids offers versatile derivatization, while maintaining potent anticancer activity, offering exciting opportunity for their use as there are no examples
    我们描述了我们的设计,合成和一组功能性表二硫代二酮哌嗪(ETPs)的化学研究,以及它们对五种人类癌细胞系的活性评估。我们的结构-活性关系指导的ETP生物碱取代提供了广泛的衍生化,同时保持了有效的抗癌活性,为它们的使用提供了令人兴奋的机会,因为没有将复杂而有效的抗癌(nM)ETP实例直接用作可结合的探针或战斗部的例子。我们对具有功能性连接子的ETP进行战略性设计的合成解决方案要求在复杂环境中进行立体选择性后期氧化和硫醇化化学方面的进展,包括应用新型试剂对二酮哌嗪进行二羟基化和顺式硫化。我们证明,配备有战略取代的叠氮化物官能团的复杂ETP易于衍生为相应的ETP-三唑,而不会损害抗癌活性。我们对ETP的化学稳定性进行研究,并对设计的ETP对A549,DU 145,HeLa,HCT 116和MCF7人类癌细胞系的细胞毒性进行评估,从而洞察了结构特征对效能和化学稳定性的影响,从而为ETP的未来应用提供了信息在化学和生物学研究中。
  • Sulfamates as antiglaucoma agents
    申请人:A. H. Robins Company, Incorporated
    公开号:US05192785A1
    公开(公告)日:1993-03-09
    Sulfamate esters of the formula (HO).sub.p --A--[OSO.sub.2 NR.sup.1 R.sup.2 ].sub.z where A is aryloxyalkyl, p is the number of unreacted hydroxy groups present on the alkyl moiety and may be zero, z is the number of --OS(O).sub.2 NR.sup.1 R.sup.2 groups attached to carbons of the alkyl moiety and is always at least one; R.sup.1 and R.sup.2 are selected from hydrogen, loweralkyl, carboxy, and the like are useful in treating glaucoma.
    Sulfamate酯的化学式为(HO).sub.p --A--[OSO.sub.2 NR.sup.1 R.sup.2 ].sub.z,其中A为芳基氧烷基,p为烷基部分上存在的未反应羟基的数量,可以为零,z为连接到烷基部分碳上的--OS(O).sub.2 NR.sup.1 R.sup.2基团的数量,始终至少为一;R.sup.1和R.sup.2从氢、低烷基、羧基等中选择,在治疗青光眼方面是有用的。
  • [EN] (THIO)MORPHOLINE DERIVATIVES AS S1P MODULATORS<br/>[FR] DÉRIVÉS DE (THIO)MORPHOLINE MODULATEURS DE S1P
    申请人:ABBOTT HEALTHCARE PRODUCTS BV
    公开号:WO2011023795A1
    公开(公告)日:2011-03-03
    The present invention relates to (thio)morpholine derivatives of the formula (I), wherein R1 is selected from cyano, (2-4C)alkynyl, (1-4C)alkyl, (3-6C)cycloalkyl, (4-6C)cycloalkenyl, (6-8C)bicycloalkyl, (8-10C)bicyclic group, each optionally substituted with (1-4C)alkyl, phenyl, biphenyl, naphthyl, each optionally substituted with one or more substituents independently selected from halogen, (1-4C)alkyloptionally substituted with one or more fluoro atoms, (2-4C)alkynyl, (1-4C)alkoxy optionally substituted with one or more fluoro atoms,amino, di(1-4C)alkylamino, -SO2-(1-4C)alkyl, -CO-(1-4C)alkyl, -CO-O-(1-4C)alkyl, -NH-CO-(1-4C)alkyl and (3-6C)cycloalkyl, phenyl substituted with phenoxy, benzyl, benzyloxy, phenylethyl or monocyclic heterocycle, each optionally substituted with (1-4C)alkyl, monocyclic heterocycle optionally substituted with halogen, (1-4C)alkyl or with phenyl optionally substituted with (1-4C)alkyl, and bicyclic heterocycle optionally substituted with (1-4C)alkyl; A is selected from -CO-O-, -O-CO-, -NH-CO-, -CO-NH, -C=C-, -CCH3-O- and the linking group –Y-(CH2)n-X- wherein Y is attached to R1 and selected from a bond, -O-, -S-, -SO-, -SO2-, -CH2-O-, -CO-, -O-CO-, -CO-O-, -CO-NH-, -NH-CO-, -C=C-and -C≡C-; n is an integer from 1 to 10; and X is attached to the phenylene / pyridyl group and selected from a bond, -O-, -S-, -SO-, -SO2 -, -NH, -CO-, -C=C-and -C≡C-; ring structure B optionally contains one nitrogen atom; R2 is H, (1-4C)alkyl optionally substituted with one or more fluoro atoms, (1-4C)alkoxy optionally substituted with one or more fluoro atoms, or halogen; and R3 is (1-4C)alkylene-R5 wherein the alkylene group may be substituted with (CH2)2 to form a cyclopropyl moiety or one or two halogen atoms, or R3 is is (3-6C)cycloalkylene-R5 or -CO-CH2-R5, wherein R5 is -OH, -PO3H2, -OPO3H2, -COOH, -COO(1-4C)alkyl or tetrazol-5-yl; R4 is H or (1-4C)alkyl; R6 is one or more substituents independently selected from H, (1-4C)alkyl or oxo; W is -O-, -S-, -SO- or -SO2-; or a pharmaceutically acceptable salt, a solvate or hydrate thereof; with the proviso that the derivative of formula (I) is not 2-(4-ethylphenyl)-4-morpholinoethanol or 4-[4-(2-hydroxyethyl)-2-morpholinyl]benzeneacetonitrile or a pharmaceutically acceptable salt, a solvate or hydrate thereof. The compounds of the invention have affinity to S1P receptors and may be used in the treatment, alleviation or prevention of S1P receptor mediated diseases and conditions.
    本发明涉及公式(I)的(硫)吗啉衍生物,其中R1从氰基,(2-4C)炔基,(1-4C)烷基,(3-6C)环烷基,(4-6C)环烯基,(6-8C)双环烷基,(8-10C)双环基团中选择,每个基团可选择地取代为(1-4C)烷基,苯基,联苯基,萘基,每个基团可选择地取代为一个或多个取代基,独立选择自卤素,(1-4C)烷基可选择地取代为一个或多个氟原子,(2-4C)炔基,(1-4C)氧烷基可选择地取代为一个或多个氟原子,氨基,二(1-4C)烷基氨基,-SO2-(1-4C)烷基,-CO-(1-4C)烷基,-CO-O-(1-4C)烷基,-NH-CO-(1-4C)烷基和(3-6C)环烷基,苯基取代为苯氧基,苄基,苄氧基,苯乙基或单环杂环烃,每个基团可选择地取代为(1-4C)烷基,单环杂环烃可选择地取代为卤素,(1-4C)烷基或取代为苯基的苯基,可选择地取代为(1-4C)烷基,和双环杂环烃可选择地取代为(1-4C)烷基;A从-CO-O-,-O-CO-,-NH-CO-,-CO-NH,-C=C-,-CCH3-O-和连接基-Y-(CH2)n-X-中选择,其中Y连接到R1并从键,-O-,-S-,-SO-,-SO2-,-CH2-O-,-CO-,-O-CO-,-CO-O-,-CO-NH-,-NH-CO-,-C=C-和-C≡C-中选择;n是1到10的整数;X连接到苯基/吡啶基团并从键,-O-,-S-,-SO-,-SO2-,-NH,-CO-,-C=C-和-C≡C-中选择;环结构B可选择地含有一个氮原子;R2是H,(1-4C)烷基可选择地取代为一个或多个氟原子,(1-4C)氧烷基可选择地取代为一个或多个氟原子,或卤素;R3是(1-4C)烷基-R5,其中烷基基团可取代为(CH2)2形成环丙基基团或一个或两个卤素原子,或R3是(3-6C)环烷基-R5或-CO-CH2-R5,其中R5是-OH,-PO3H2,-OPO3H2,-COOH,-COO(1-4C)烷基或四唑-5-基;R4是H或(1-4C)烷基;R6是一个或多个取代基,独立选择自H,(1-4C)烷基或氧代基;W是-O-,-S-,-SO-或-SO2-;或其药学上可接受的盐,溶剂或水合物;但是,公式(I)的衍生物不是2-(4-乙基苯基)-4-吗啉乙醇或4-[4-(2-羟乙基)-2-吗啉基]苯乙腈或其药学上可接受的盐,溶剂或水合物。本发明的化合物具有对S1P受体的亲和力,可用于治疗、缓解或预防S1P受体介导的疾病和症状。
  • [EN] ANTIBACTERIAL BENZOIC ACID DERIVATIVES<br/>[FR] DERIVES D'ACIDES BENZOIQUES ANTIBACTERIENS
    申请人:UPJOHN CO
    公开号:WO2004018428A1
    公开(公告)日:2004-03-04
    The invention provides antimicrobial agents and methods of using the agents for sterilization, sanitation, antisepsis, disinfection, and treatment of infections in mammals.
    这项发明提供了抗菌剂和使用这些剂进行哺乳动物的消毒、卫生、防腐、消毒和治疗感染的方法。
查看更多